Oncoinvent ASA: Minutes from Extraordinary General Meeting

Oslo, Norway, 8 January 2026: An extraordinary general meeting of the Company was held today, 8 January 2026, by electronic means through Lumi AGM. The general meeting, inter alia, resolved i) audited interim balance sheet, ii) a reverse share split, iii) a capital reduction, and iv) proxy to the Board of Directors.

The complete minutes of the extraordinary general meeting are attached to this release and are also available on the Company's website, https://www.oncoinvent.com/.

Please see Minutes from EGM here.

This information is subject to the disclosure requirements pursuant to Section 5-12 of the Norwegian Securities Trading Act.